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RELATO DE CASO 
ASHY DERMATOSIS - A CASE REPORT FROM PALMAS - TO 
DERMATOSE CINZENTA (EDP) UM RELATO DE CASO EM       
PALMAS – TO 
Isabella Vieira Borges¹, Laura Barcelos Azzam¹, Fernanda Vieira Nascimento 
Gomes¹, Júlia Artiaga de Carvalho Coelho¹, Fellipe Magela de Araujo², Yasmin 
Pugliesi², Luciane Prado Silva Tavares³. 
ABSTRACT 
INTRODUCTION: Ashy dermatosis is a rare dermatosis of unknown etiology and 
pathogenesis, more common in people with darker skin. However, in this case report, the 
patient is white. CASE REPORT: A 54-year-old white woman with a history of asymptomatic 
gray-stained macules located on the craniocaudal axis. Despite a positive antinuclear 
antibody (ANA) test, the use of Plaquinol was suspended due to the fact that the patient did 
not present rheumatologic affections. A biopsy compatible with the condition of ashy 
dermatosis and post-inflammation pigmentation was performed. However, the 
anatomopathological examination revealed superficial perivascular dermatitis with 
pigmented incontinence and skin fragments, a discreet superficial perivascular inflammatory 
mononuclear infiltrate and mild pigmentary incontinence, confirming the clinical hypothesis 
of ashy dermatosis. A skin lightening lotion (Arbutin 4%, Chromabright 0.5%, Alfabisabol 1%, 
Nicotinamide 4%, Kojico Acid 3%, Nonionic Cream) was used for 30 days with satisfactory 
results, along with the substitution of antihypertensive medication. FINAL CONSIDERATIONS: 
The report is relevant because it is necessary to know this pathology for differential diagnosis 
of pigmented dermatosis and so that the best treatment can be prescribed. 
Keywords: Ashy Dermatosis; Hyperpigmentation; Erythema Dyschromicum Perstans. 
 
RESUMO 
INTRODUÇÃO: A dermatose cinzenta é uma dermatose rara, de etiologia e patogenia 
desconhecida, mais comum em pessoas de pele mais escura, porém no caso relatado a 
paciente é branca. RELATO DE CASO: Mulher de 54 anos de idade, branca, com história de 
máculas de coloração acinzentada, assintomáticas, localizadas no eixo craniocaudal. Apesar 
do FAN positivo, o uso de Plaquinol foi suspenso pela paciente não apresentar afecção 
reumatológica. Foi realizada uma biópsia compatível com o quadro de dermatose cinzenta 
bem como pigmentação pós-inflamação. No entanto, no exame anatomopatológico foi 
encontrada dermatite perivascular superficial com incontinência pigmentar e em fragmentos 
de pele, um discreto infiltrado inflamatório mononuclear perivascular superficial e leve 
incontinência pigmentar, confirmando a hipótese clínica de dermatose cinzenta. Uma loção 
clareadora (Arbutin 4%, Chromabright 0,5%, Alfabisabol 1%, Nicotinamida 4%, Ácido Kojico 
3%, Creme não iônico) foi utilizada por 30 dias apresentando resultados satisfatórios, além 
da substituição do anti-hipertensivo. CONSIDERAÇÕES FINAIS: O relato é relevante pois deve-
se conhecer essa patologia para diagnose diferencial das dermatoses pigmentadas e desta 
forma optar pela melhor conduta terapêutica. 
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Ashy dermatosis or erythema dyschromicum perstans 
(EDP) is a clinical syndrome characterized by grayish-
blue hyperpigmentation of skin, with slow, chronic and 
benign progression. Clinically, it is presented with numerous 
grayish-blue stains of different sizes, slightly raised 
erythematous margins, occurring mostly on the face, trunk 
and upper limbs. [1- 7] They are typically asymptomatic and tend 
to coalesce, sparing mucous membranes, palms, soles 
and scalp. 
Initially described by Ramirez in 1957, ashy dermatosis 
is more common in darker-skinned people, such as Latin 
Americans and indigenous population, and does not suffer 
influence from the environment, food, nor occupation, but has 
been reported in people with lighter skin 
and diverse ethnicities. It is a rare condition whose etiology is 
undetermined. However, associations with endocrinopathies, 
nematode infestations, exposure to pesticides, cobalt allergy, 
administration of radiological contrast and HIV infection are 
mentioned. [6-7] 
We report the case of a patient with a diagnosis of 
ashy dermatosis previously treated as other pathologies. It is 





A 54-year-old white female patient noticed the onset 
of a gray-stained macule in the chin region with subsequent 
onset of similar lesions in the abdomen, and upper and lower 
limbs. She underwent treatment with Hydroxychloroquine 
sulfate (Plaquenil) for eight months. However, 
the rheumatologist suspended the treatment due to the fact 
that the patient did not have a rheumatologic disease, although 
the ANA test was positive, causing the suspicion of systemic 
erythematosus lupus. 
Dermatological examination demonstrated 
the generalized presence of hyperchromic spots, with a chronic 
course, affecting the craniocaudal axis (See images below). The 
patient denied having erythema prior to the greyish macules, 
local pruritus, and that it worsened with sunlight.   
 
Figure 1: macules on chest Figure 2: macules on neck 
  
Figure 3: macules on back Figure 4: macules on arm 
An inventory of medications in use, along with foods 
and chemicals was requested to exclude other pathologies that 
could be linked to these products. This led to the suspension, 
until the definitive diagnosis, of the use of formaldehyde in hair 
products. Also, Vasopril (antihypertensive) was traded for 
testing, since as possible adverse effects there are severe skin 
reactions or other skin manifestations. 
In order to lighten the lesions, the use of Laser CO2 
was attempted – High 10 3 #/ Acroma 5mm on the right 
forearm / 7mm Acroma in the left forearm. However, it did not 
present satisfactory results. In 2014, a biopsy that was 
performed was compatible with fixed pigment erythema, but it 
is not such clinically.  
In another biopsy performed in 2016, pathology 
verified the presence of superficial perivascular dermatitis with 
pigment incontinence and skin fragments, a discreet superficial 
perivascular mononuclear inflammatory infiltrate and mild 
pigmentary incontinence. Such morphological findings, though 
subtle, suggest the clinical hypothesis ashy dermatosis 
(Persistent Dyschromatic Erythema) as well as post-
inflammation pigmentation. 4  
Lightening lotion (Arbutin 4%, Chromabright 0.5%, Alf
abisabol 1%, Nicotinamide 
4%, Kojico Acid 3%, Nonionic Cream) was then prescribed por 
use at night on all spots, and after 30 days, it was observed that 
lightening of the macules and skin rejuvenation 
occurred. However, there was no lightening of the infra-
mammary region and of the upper limbs’ macules. Thus, the 





              Ashy dermatosis still has unknown etiology 
and pathogenesis. However, infections, intoxications and 
sensitization to allergens are likely causes. 7.8 
              Clinically, it is characterized by slow growing grayish-
brown to grayish-blue macules, which vary from 0.5 to several 
centimeters, distributed symmetrically or not. They are found 
preferentially on the face, cervical region, cervix, trunk, and 
limbs in their proximal region. Initially, it presents itself in a 
localized form and disseminates through a peripheral thin 
erythematous border, that may be 1 to 2mm thick. This border 
is present in acute lesions, but may be replaced by a 
hypochromic halo. [4- 12] An important fact is that ashy 
dermatosis appears more often in patients with darker colored 
skin, but the patient reported is white. 
              As for the histopathological findings, there isn’t a 
specific pattern, and include vacuolization of the basal 
layer, necrosis of basal keratinocytes, colloid bodies, 
lymphocyte exocytosis, pigmentary 
incontinence and lymphocytic inflammatory perivascular 
infiltrate.4 In the patient described, the superficial 
inflammatory perivascular infiltrate and slight pigmentary 
incontinence were discreetly found. 
              As for differential diagnosis,  lichen planus 
pigmentosus, post-
inflammatory hyperpigmentation, figurative erythema, drug 
induced rashes, Addison's disease and hemochromatosis 
should be mentioned. Among these, lichen planus pigmentosus 
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is the most similar dermatosis to ashy dermatosis, and was 
considered a variant of lichen planus in the past. Nowadays, 
they are considered pigmentary disorders, separated by most 
authors. 4 
              Numerous treatments have been proposed for the 
condition, due to the fact that a standard therapy has not yet 
been established. Due to a lack of consistent results, it was 
decided that 
a lightening lotion (Arbutin 4%, Chromabright 0.5%, Alfabisabo
l 1%, Nicotinamide 4%, Kojico Acid 3%, Nonionic Cream) would 




Ashy dermatosis is a rare pigmentary disorder where 
the skin changes colors to a grayish-blue. This pathology should 
be known for the differential diagnosis of pigmented 
dermatoses and, therefore, for the best therapeutic 
approach to be chosen. It appears more frequently in darker 
skinned people, although the patient reported is white, which 
is even more curious, from a scientific point of view. 
Until now, there are few reports about this syndrome, 
especially current ones, corroborating with those already 
existing and showing other forms of successful treatment, such 
as this report, which shows the use of a skin lightening lotion to 
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